Cristalia products with Nemera’s reusable pen injector commercialized in Brazil.
Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.
Continue Reading
![](https://www.nemera.net/wp-content/uploads/2024/01/Crispen-caixa-white-back.png)
![](https://www.nemera.net/wp-content/uploads/2024/01/Crispen-caixa-white-back.png)